Cytek Biosciences, Inc. (CTKB)
Laboratory Analytical Instruments
Latest Price
$4.22
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
2.55
P/B Ratio
1.66
Valuation metrics
adjust assumptions →Base FCF: $633,000 (median of recent 5yr)
Growth: 25%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$1.07
75% downside
Institutional Ownership
65.2% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 17.01M | $74.0M | 13.17% | -165.8K | 2026-03-31 |
| Topline Capital Management, LLC | 7.06M | $30.0M | 5.47% | -378.0K | 2026-03-31 |
| HHLR ADVISORS, LTD. | 6.66M | $29.0M | 5.15% | -- | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 6.29M | $27.0M | 4.87% | +1.54M | 2026-03-31 |
| Boston Partners | 5.80M | $25.0M | 4.49% | +794.5K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.76M | $20.0M | 3.69% | -- | 2026-03-31 |
| STATE STREET CORP | 4.12M | $18.0M | 3.19% | -23.2K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.83M | $12.0M | 2.19% | +43.4K | 2026-03-31 |
| DIMENSIONAL FUND ADVISORS LP | 2.66M | $11.0M | 2.06% | +16.4K | 2026-03-31 |
| GOLDMAN SACHS GROUP INC | 2.34M | $10.0M | 1.82% | +554.8K | 2026-03-31 |